ask="3.3900"
ask_size="200"
average_daily_volume="33690"
bid="2.8200"
bid_size="100"
book_value="0.4940"
change="-0.1901"
change_from_200_day_moving_average="-0.3400"
change_from_50_day_moving_average="-0.2568"
change_from_52_week_high="-5.6001"
change_From_52_week_low="0.5899"
change_in_percent="-5.2953%"
close="3.3999"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.4210"
ebitda="-15.65M"
eps_estimate_current_year="-1.6200"
eps_estimate_next_quarter="-0.3600"
eps_estimate_next_year="-1.4900"
ex_dividend_date="N/A"
float_shares="5060000"
high="3.6971"
high_52_weeks="9.0000"
last_trade_date="1/19/2017"
last_trade_price="3.3999"
last_trade_size="156"
last_trade_time="3:58pm"
low="3.3500"
low_52_weeks="2.8100"
market_capitalization="28.49M"
moving_average_200_day="3.7399"
moving_average_50_day="3.6567"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.5000"
open="3.5500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-9.0919%"
percent_change_from_50_day_moving_average="-7.0220%"
percent_change_from_52_week_high="-62.2233%"
percent_change_from_52_week_low="+20.9929%"
previous_close="3.5900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.2672"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.7200"
stock_exchange="NCM"
symbol="VTGN"
volume="32991"
weeks_range_52="2.8100 - 9.0000"
